Axonics, Inc. (NASDAQ:AXNX – Get Free Report) has been given a consensus recommendation of “Hold” by the thirteen research firms that are currently covering the company, Marketbeat Ratings reports. Eight research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective […]